Human IL17RE activation kit by CRISPRa

CAT#: GA115162

IL17RE CRISPRa kit - CRISPR gene activation of human interleukin 17 receptor E



  See Other Versions

CNY 12,255.00


货期*
4周

规格
    • 1 kit

Product images

经常一起买 (3)
Rabbit Polyclonal IL-17RE Antibody
    • 100 ug

CNY 5,808.00


IL17RE (Myc-DDK-tagged)-Human interleukin 17 receptor E (IL17RE), transcript variant 6
    • 10 ug

CNY 3,968.00
CNY 4,660.00


IL17RE Rabbit polyclonal Antibody
    • 100 ul

CNY 1,999.00
CNY 3,280.00

Specifications

Product Data
Format 3 gRNAs (5ug each), 1 scramble ctrl (10ug) and 1 enhancer vector (10ug)
Symbol IL17RE
Locus ID 132014
Kit Components

GA115162G1, IL17RE gRNA vector 1 in pCas-Guide-GFP-CRISPRa

GA115162G2, IL17RE gRNA vector 2 in pCas-Guide-GFP-CRISPRa

GA115162G3, IL17RE gRNA vector 3 in pCas-Guide-GFP-CRISPRa

1 CRISPRa-Enhancer vector, SKU GE100056

1 CRISPRa scramble vector, SKU GE100077

Disclaimer These products are manufactured and supplied by OriGene under license from ERS. The kit is designed based on the best knowledge of CRISPRa SAM technology. The efficiency of the activation can be affected by many factors, including nucleosome occupancy status, chromatin structure and the gene expression level of the target, etc.
Reference Data
RefSeq NM_001193380, NM_144640, NM_153480, NM_153481, NM_153482, NM_153483, NR_104198
Synonyms FLJ23658; MGC71884
Summary This gene encodes a transmembrane protein that functions as the receptor for interleukin-17C. The encoded protein signals to downstream components of the mitogen activated protein kinase (MAPK) pathway. Activity of this protein is important in the immune response to bacterial pathogens. Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2013]
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Documents

Other Versions

Customer Reviews 
Loading...